Site Management/Investigator Payments Featured Articles
-
Clinical Sites Are Optimistic, Despite Growing Challenges
1/17/2023
The last few years have not been easy for sites involved with conducting clinical research. The onset of the pandemic in 2020 created numerous challenges, including the implementation of new technologies and operating models, the leveraging of remote staff, and virtual facilities. Despite the ongoing challenges, global sites remain optimistic about the future of clinical trials.
-
How Can Clinical Research Better Navigate Healthcare Deserts?
1/17/2023
Large swaths of the U.S. remain healthcare deserts, where access to clinical sites, pharmacies, and hospitals is limited. This contributes to underrepresentation in clinical research. What are the roles of technology and community outreach, and what are some current industry efforts to address it?
-
How CVS, Walgreens, And Walmart Will Improve Clinical Trial Recruitment
11/30/2022
A new development could potentially change the patient recruitment challenge. In 2022, CVS, Walgreens, and Walmart officially entered the clinical trials space. The patient access capabilities of all three organizations may change the way drug developers access patients while also solving the patient diversity problem.
-
Survey Reveals High Levels Of CTIS Adoption In Europe
11/8/2022
Early feedback from users of the EMA’s new centralized clinical trials information system (CTIS) is broadly positive, according to a survey of 400 U.S. and European life science leaders. CTIS use isn’t mandatory until after the end of January 2023, but industry uptake has already been strong.
-
India’s New Drugs, Medical Devices, And Cosmetics Draft Bill 2022
11/7/2022
To accommodate changing requirements and encourage the adoption of new technology, India’s Ministry of Health and Family Welfare released a draft bill in July 2022 to replace the existing Drugs and Cosmetics Act 1940. What are the major areas of change and how much of an impact will there be?
-
Should We Pay Patients In Clinical Trials For Their Time?
9/29/2022
Many countries don't reimburse clinical trial patients for their time and inconvenience. Is it ethical to pay them or not? This article looks at the perspectives of some of the major regulatory authorities. Can we find common ground? What actions can we take as members of industry?
-
Clinical Trials In APAC: Challenges And Opportunities
9/29/2022
For several years, the APAC region has been one of the hottest growth regions for clinical trials. In June 2022, I had the opportunity to sit down with three experts on the region. They were able to discuss the growth of trials in the APAC region, the opportunities presented to sponsor companies, and the challenges that still exist.
-
Top Site Complaints: Budgets, Communication, And Technology
9/27/2022
Technology firm Greenphire conducts an annual survey to determine the trending issues that matter most to clinical sites. Last year the company asked me if there was a question that I would like to see included in their survey. I requested that Greenphire ask its survey takers about the one thing they would like sponsor companies to do for them. The sites responded.
-
Nonprofit Org Sees A New Way To Train CTA Talent
9/20/2022
Training the next generation of life sciences talent is a challenge that MassBioEd, a Massachusetts-based non-profit 501(c)(3) organization with a mission to build a sustainable life sciences workforce in the region, is working to solve. It recently created two apprenticeship programs, one of which is for clinical trial associates.
-
The Impact Of The Russia–Ukraine War On Clinical Trials
9/7/2022
While the export of life-saving pharmaceuticals does not fall under sanctions for ethical reasons, all major pharma companies have vowed to stop new investments in Russia, including clinical trials. This author takes a "by the numbers" research look at the situation and analyzes where sponsor companies should reallocate clinical trials out of the affected region.